Damian Sofrevski: Ledger

Stories naming Damian Sofrevski. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Founder	Neurode	Forbes Australia, refractor.io, SmartCompany

13 deals

Meet the Aussies on the 2025 Forbes 30 Under 30 Asia list

Forbes Australia 15 May 2025 Adrielle Touma Alexander Valente Alexis Aaron Andrew Pankevicius Andromeda Robotics Annabel Hay Bianca Stern Charlotte Vieira CLUTCH Glue Connor Balfany Damian Sofrevski Daniel Palmer Daniel Vassilev Dylan Coyne Elliephant Gaby Rosenberg Grace Brown Holly Fowler Humpday Isabella Choate Jacky Koh Jodine Wolman Kim Russell Loughlan Dalton de Burgh Lucas Sargent Mary Fowler Matthew Blode Natasha Etschmann Neurode Pretty Privilege Redactive Relevance AI Sara Webb Sortd The Leaf Protein Co.UpDoc AirTree Ventures Australian Financial Review Australian Securities Exchange Basketball Australia Blossom App Catch Constantinople ELMO Software EQ Fingertip Flying Fox Ventures Forbes Australia Fortlake Asset Management Get Rich Slow Club Government of New South Wales Linktree Luxury Escapes MA Growth Ventures Manchester City Mass Dynamics Menulog PredictHQ Rampersand Swinburne University of Technology Tash Invests The Kimbino University of Melbourne Wable Western Australian government Youth Disability Advocacy Network Antler Australia Atlassian Ventures Bailador Technology Investments Bessemer Venture Partners Blackbird Ventures Felicis Galileo Ventures Khosla Ventures King River Capital LaunchVic Loyal VC Peak XV Purpose Ventures Darryl Garber Ned Coten Ali Rosenberg Gabby Leibovich Hezi Leibovich

Funding announcement

World-first ADHD headband treats symptoms in 20 minutes per day

Australian startup Neurode has raised A$5.3 million to bring its ADHD headband, which stimulates the brain's focus region for 20 minutes daily, to market; US beta sign-ups are open.

refractor.io 18 Sep 2024 Neurode Damian Sofrevski Nathalie Gouailhardou

Unnamed stage $5.3m

Neurode secures $5.3 million for its non-invasive, wearable ADHD solution

Sydney medtech Neurode has raised $5.3 million to refine its ADHD headband, run a clinical trial and open a private beta, offering drug-free brain stimulation for focus, memory and impulse control.

SmartCompany 13 Sep 2024 Neurode Damian Sofrevski Nathalie Gouailhardou

Also Forbes Australia

Damian Sofrevski

Roles

Coverage

Meet the Aussies on the 2025 Forbes 30 Under 30 Asia list

World-first ADHD headband treats symptoms in 20 minutes per day

Neurode secures $5.3 million for its non-invasive, wearable ADHD solution